v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Total revenues $ 44,203,000 $ 47,831,000
Cost of sales (17,158,000) (15,524,000)
Gross profit 27,045,000 32,307,000
Operating expenses:    
Selling, general and administrative 43,230,000 40,513,000
Research and development 5,895,000 3,026,000
Total operating expenses 49,125,000 43,539,000
Loss from operations (22,080,000) (11,232,000)
Interest expense, net (5,497,000) (6,548,000)
Loss before income taxes (27,577,000) (17,780,000)
Income tax expense (25,000)
Net loss $ (27,602,000) $ (17,780,000)
Basic net loss per share of common stock $ (0.74) $ (0.50)
Diluted net loss per share of common stock $ (0.74) $ (0.50)
Weighted average number of shares of common stock outstanding, basic 37,231,321 35,826,452
Weighted average number of shares of common stock outstanding, diluted 37,231,321 35,826,452
Product Sales Net [Member]    
Revenues:    
Total revenues $ 44,130,000 $ 47,745,000
Other Revenues [Member]    
Revenues:    
Total revenues $ 73,000 $ 86,000